Turn interaction into intelligence! Don’t miss this chance to lead the industry with our free pharma-exclusive webinar!

Little Green Pharma Ltd. (AU:LGP) has released an update. Little Green Pharma Ltd. is hosting an investor webinar where CEO Paul Long will present the Quarterly Activities Report for September 2024.

Nxera Pharma Co. Ltd ('Nxera”; TSE 4565) will announce its earnings results and present operational highlights for the year ...

BridgeBio Pharma, Inc. announced it will host an investor webinar on July 11, 2025, at 8:00 am ET, featuring Dr. Matthew Wicklund from the University of Texas Health Science Center. The webinar will ...

In this free webinar, learn how to validate R for clinical use while maintaining appropriate controls. The featured speakers will discuss how R and SAS can be used together without undermining ...

Trademarks in the pharmaceutical industry are important not only as part of a company’s intellectual property portfolio, but also as a matter of public health, and obtaining a trademark registration ...

TORONTO, Feb. 2, 2026 /PRNewswire/ -- Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries. Access to all ...

Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and ...

This webinar will explore the applications of Dynamic Light Scattering (DLS) and Electrophoretic Light Scattering (ELS) in the pharmaceutical industry. The experts will discuss how these techniques ...

Pharmaceutical R&D and quality control face increasing demands for speed, scalability, and regulatory compliance – yet many workflows remain manual, fragmented, and resource-intensive. In this webinar ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Elemental Impurities: The New Requirements" webinar to their offering. This webinar is designed to provide a ...